2022-03-29 18:00:00
Point-of-Care/Contact HIV Testing
Poster #1: HIV Test Preferences in an Urban Hospital Emergency Department
1Jacobi Medical Center, Bronx, NY
2Albert Einstein College of Medicine, Bronx, NY
Poster #2: Aware™ in retrospective: a multi-year, multi-country evaluation of an oral fluid HIV-1/2 Rapid Test.
CW Hooker
Calypte Biomedical Corporation Portland, OR USA
Poster #3: Rapid HIV Testing Programs in Urban Emergency Departments – Comparison of Results from Inner-City and Urban Sites in Baltimore, Maryland
Y.-H. Hsieh, L. Harvey, A. Burah, R.E. Rothman
Department of Emergency Medicine, The Johns Hopkins University School of Medicine, Baltimore, Maryland
Poster #4: HIV Rapid Testing Quality Assurance Program and Evaluation of HIV Rapid testing technologies in Ethiopia
Getachew Belay, Belete Tegbaru, Gudeta Tibesso
Ethiopian Health and Nutrition Research Institute (EHNRI), Addis Ababa, Ethiopia
Poster #5: RETESTING AS A TOOL FOR QUALITY ASSURANCE OF HIV RAPID TEST AT POINT-OF-CARE IN RESOURCE LIMITED SETTINGS
I.M. Livinus1, M. Okoye2, E. Iwe1, O. Salami1, E. Omorogbe1, C. Ntagbu3, D. Olorunmeye4.
1Management Sciences for Health, Abuja-Nigeria
2United States Agency for International Development, Abuja-Nigeria
3HIV Research Lab Division, General Hospital New Bussa, Niger State
4State Specialist Hospital Lokoja, Kogi State
Poster #6: Assessment of HIV test Discordance in a Serial Testing Algorithm
M.I.J Okoye (USAID/NIGERIA, Abuja, FCT, Nigeria), L. Okoye (FHI/GHAIN, Abuja, FCT, Nigeria), I. Wurie (CDC/Nigeria, Abuja, FCT, Nigeria)
Poster #7: Single Rapid HIV Testing and Entry into Care: Experience in New Jersey, 2005 – 2006
UMDNJ, School of Public Health, Newark, NJ, USA NJ Dept of Health and Senior Services, Division of HIV/AIDS, Trenton, NJ, USA NJ Dept of Health and Senior Services, Division of HIV/AIDS, Trenton, NJ, USA UMDNJ, NJ Medical School and School of Public Health, Newark, NJ CDC, Division of HIV/AIDS Prevention, Atlanta, GA, USA
Poster #8: Evaluating and balancing quality and costs in rapid HIV Quality Assurance
Salaru G, Cadoff EM, Paul SM, and Martin EG
UMDNJ – Robert Wood Johnson Medical School, Department of Pathology & Laboratory Medicine, Somerset, NJ.
Poster #9: Performance of a Rapid HIV Test as the Primary Screening Tool at a Community Health Center in Houston, Texas
Scott, J*.,Turner, C., York, S., Broussard, T., and Pottumarthy, S.
Bureau of Laboratory Services, Houston Department of Health and Human Services, Houston, TX, USA
Poster #10: Performance of the OraQuick Advance® Rapid HIV-1/2 test in a HIP HOP for HIV Awareness and Intervention Program in Houston, Texas
York, S.,* Turner, C., Scott, J., and Pottumarthy, S.
Bureau of Laboratory Services, Houston Department of Health and Human Services, Houston, TX, USA.
Poster #11: Improved Oral Fluid Specificity of the Enhanced OraQuick ADVANCE Rapid HIV 1/2 Oral Fluid Antibody Test
OraSure Technologies, Inc., Bethlehem, PA, USA
Poster #12: Translation isn’t just about foreign language: bridging the language gap with HIV testing
Facente Consulting, San Francisco, CA, USA
Poster #13: Using photographed rapid HIV test results to pilot an EQAS
Chiu C, Ong J, Walker S and Dax EM
National Serology Reference Laboratory, Australia; St Vincent’s Institute, Fitzroy, Australia
Poster #14: The Significance and Value of External Quality Assessment for HIV-1 Testing
National Serology Reference Laboratory, Australia, 41 Victoria Parade, Fitzroy 3065
Poster #15: Comparison of Dried Tube and Plasma Specimens in an External Quality Assurance (EQA) Scheme and Evaluation of Quality of HIV Rapid Testing Performed by Non-Laboratory Staff in Lesotho.
APHL, Silver Spring, MD, CDC/GAP ILB; CDC Lesotho, and Lesotho Ministry of Health and Social Welfare (MOHSW)
Poster #16: Correlation of preliminary positive HIV antibody assays performed on the ADViA Centaur CIA to WB: A one year look back
Montefiore Medical Center, Bronx, New York, USA
Poster #17: Is positive antibody detection on a chemiluminescence (CIA) HIV immunoassay in the presence of a negative western blot (WB) always a false positive?
Montefiore Medical Center, Bronx, NY, USA
Poster #18: The High Positive Immunoassay Confirms HIV-1 Infection and Avoids the Need of Confirmatory Tests
The Department of Internal Medicine and the Clinic of Sexually Transmitted Diseases, Regional Hospital of Colima; the Department of Internal Medicine, General Hospital 1, Colima, and the Health Research Council in Jalisco State, Mexican Institute of Social Security.
Poster #19: Evaluation of the ADVIA Centaur® HIV 1/O/2 Enhanced (EHIV) Assay
ARUP Laboratories, Salt Lake City, UT, USA
Poster #20: Validating supplemental oral fluid testing for preliminary positive rapid HIV tests
University of Maryland School of Medicine, CDC, UMMS, Cairo Univ Faculty of Science Baltimore, MD 21201, USA
Poster #21: Correlation on the Use of a Reactive Signal to Cutoff Threshold Value in a 3rd Generation HIV-1/2 Antibody Immunoassay to Expedite Supplemental Testing and Reduce Screening Costs
Florida Department of Health, Bureau of Laboratories-(Jacksonville1, Miami2) FL., USA
Poster #22: Performance of the Ortho Vitros HIV1/2 Assay in a Pregnant Population, Including at Delivery
Departments of Pathology1 and Pediatrics2, University of Texas Medical Branch, Galveston, Texas 77555
Poster #23: Standardization and Monitoring of Laboratory Performance and Quality Assurance Using the Less-Sensitive HIV Incidence Assay: Seven Years of Results
J.V. Mei, M. Kennedy, L. Linley, D. Hanson, J. Schiffer, S. Ethridge, B. Branson
Centers for Disease Control and Prevention, Atlanta, Georgia USA
Poster #24: Development of a Bead-based, Multiplex Assay for Estimation of Recent HIV-1 Infection
Kelly A. Curtis, M. Susan Kennedy, Debra Candal, Debra Hanson, Kevin Delaney, Man Charurat, Steve McDougal and S. Michele Owen
Division of HIV/AIDS Prevention, Centers for Disease Control and Prevention, Atlanta, GA
Poster #25: Fiebig Stage and Recency: What’s the Relationship?
PE Garrett, M Manak and MP Busch
SeraCare Life Sciences and Blood Systems Research Institute Milford, MA and San Francisco, CA
Poster #26: Seroconversion Panels for the Validation of 3rd and 4th Generation HIV Assays
ZeptoMetrix Corporation, 872 Main Street, Buffalo, NY 14202
Poster #27: Evaluation of HIV RNA detection to increase ascertainment of primary HIV infection
G Murphy, S.Carne, B.Patel, C. Hill, A.Charlett, E.Mckinney, O.N. Gill, J.V. Parry and J. Tosswill
Poster #28: Evaluation of an FDA-approved qualitative RNA detection assay for diagnosis of HIV-1 infection in perinatally exposed infants
Wadsworth Center, New York State Department of Health, Albany, NY
Poster #29: An evaluation of pooling strategies for acute HIV-1 infection screening using nucleic acid amplification testing
Wadsworth Center, New York State Department of Health, Albany NY Division of HIV/AIDS Prevention, Centers for Disease Control and Prevention, Atlanta GA
Poster #30: A High Throughput, Cost Effective System for Acute HIV Detection in Health Department STD Clinics, New York City, May 5, 2008 – September 16, 2009
Goldsmith J*, Smith R*, Kowalski A, Blank, S, Faruki H*
*National Genetics Institute, Laboratory Corporation of America, Los Angeles, CA
Poster #31: Sensitivity of OraQuick and Early Generation Enzyme Immunoassay (EIA) within a Pooled HIV Nucleic Acid Amplification Testing (HIV NAAT) Program
J Stekler1,2, PD Swenson2, RW Coombs1, J Dragavon1, RW Wood1,2, MR Golden1,2
1University of Washington, Seattle, WA
2Public Health - Seattle & King County, WA
Poster #32: Evaluation of Dried Blood Spots for Human Immunodeficiency Virus (HIV-1) Drug Resistance Testing
Dawit Assefa1, Woldaregay Eriku2, Teferi Gedif2, Belete Tegbaru1, Dereje Teshome1, Tesfaye Tilahun1, Hiwot Birhanu1, Mesfin Kebede1, Almaz Abebe1
1Ethiopian Health and Nutrition Research Institute
2Addis Ababa University
Poster #33: Continued Repetitive HIV Western Blot Testing Post-HIV Diagnosis and Association with Care Engagement
Weis KE, Stephens T, Gibson JJ, Duffus WA
School of Medicine, University of South Carolina, Columbia, SC South Carolina Department of Health and Environmental Control, Columbia, SC
Poster #34: Evaluation of the IsoAmp® HIV detection kit Using Whole Blood Samples
J.A. Jordan, O.C. Ibe, G. Simon
The George Washington University, School of Public Health and Health Services, Washington, DC
Poster #35: Identification of Performance problems in the Abbott HIV-1&2 gO EIA by multiuser external quality control monitoring and real-time data analysis.
National Laboratory for HIV Reference Services, Public Health Agency of Canada, Ottawa, Ontario.
Poster #36: Rapid extraction and amplification of HIV-1 DNA from whole blood using a disposable microfluidics device
Timothy C. Granade1, Susan K. Wells1, Joan Haab2, John Gerdes2, Sabrina Gates2, Michele Owen1 and Chou-Pong Pau1
1Centers for Disease Control and Prevention, Division of HIV/AIDS Prevention, Atlanta, GA
2Micronics, Inc., Redmond, WA
Poster #37: A Rapid Portable HIV Detection & Monitoring System for Low Resource Settings
Joel W. Grover, Ph.D.1 and Katherine Luzuriaga, M.D.2
1Thermal Gradient Inc, Pittsford, NY, USA
2UMass Medical School, Worcester, MA, USA
Poster #38: Detection of Human Immunodeficiency Virus Type 2 (HIV-2) Using a Real Time RT-PCR Assay with a Whole Virus Internal Control
Linda M. Styer, Binshan Shi, and Monica M. Parker
Wadsworth Center, New York State Department of Health, Albany, NY School of Public Health, University of Albany, Albany, NY
Poster #39: Development of a simple, rapid and inexpensive method for the qualitative detection of HIV-1 RNA
Chou-Pong Pau, Susan K. Wells, S. Michele Owen, and Timothy C. Granade.
Centers for Disease Control and Prevention, Division of HIV/AIDS Prevention, Atlanta, Ga 30329
Poster #40: Innovative point-of-care HIV viral load detection in RLS
Wave 80 Biosciences, San Francisco, CA, USA
Poster #41: SMARTube™ as a Test for Recent Infection
University of the Witwatersrand, School of Computational and Applied Mathematics, Johannesburg, South Africa; South African DST/ NRF Centre for Epidemiological Modelling and Analysis (SACEMA), Stellenbosch, South Africa
Poster #42: Preparation of Reference Panels for Current and Emerging HIV Variants
Mark Manak1, Bharathi Anekella1, Michael Busch2, Marion Vermeulen3, Susan Stramer4, Sodsai Tovanabutra5, Robert Coombs6, David Montefiori7, Patricia Garrett1, Marco Schito8
1SeraCare Life Sciences, Gaithersburg, MD
2Blood Systems Research Institute, San Francisco, CA
3South African National Blood Service, Johannesburg, S. Africa
4American Red Cross, Gaithersburg, MD
5U.S. Military HIV Research Program, Rockville, MD
6University of Washington, Seattle, WA
7Duke Human Vaccine Institute, Durham, NC
8Henry Jackson Foundation/DAIDS/NIH, Bethesda, MD
Poster #43: Characterization of Immune Responses to Capsid Protein (p24) of Human Immunodeficiency Virus Type 1: Implications for Detection
Lab of Molecular Virology, Center for Biologics Evaluation and Research, Food and Drug Administration, Bethesda, MD, USA
Poster #44: Mother to child transmission of HIV-1 infection in UK – how soon can a diagnosis be made?
Centre for Infections, Health Protection Agency, London, UK
The New Landscape of HIV Testing in Laboratories, Public Health Programs and Clinical Practice